Free Trial Program Terms and Conditions

 

DAWNZERA™ (donidalorsen) Free Trial Program Details

The Free Trial Program (FTP) provides eligible patients who are new to DAWNZERA with a one-time, one-dose supply of DAWNZERA at no charge to assess the administration process and evaluate the tolerability of DAWNZERA prior to prescription. The program is offered through Ionis Pharmaceuticals and is managed by Ionis Every Step™.

 

Eligibility Criteria

To be eligible for the FTP program, a patient must meet ALL the following eligibility criteria:

• Patient must be a new patient who has not previously been treated with DAWNZERA
• Ionis Every Step must receive a healthcare provider signed, valid Free Trial Program prescription for a U.S. Food and Drug Administration-approved indication for DAWNZERA
• Patient must be enrolled in and consent to Ionis Every Step support program for DAWNZERA
• Available only to patients in the U.S. & Puerto Rico
• All patients are eligible, including patients with Medicare and Medicaid

 

Additional Terms

The Ionis Every Step Free Trial Program ("FTP"), sponsored by Ionis Pharmaceuticals, Inc., the manufacturer of DAWNZERA, provides a one-time, one-dose supply of DAWNZERA to patients who meet FTP eligibility requirements and who agree to the FTP terms and conditions by submitting a signed consent form. FTP is a free trial offer, intended solely to allow patients who are new to DAWNZERA to determine with their healthcare provider whether DAWNZERA is right for them. There is no obligation to continue use of DAWNZERA after the free trial has been completed. To be eligible, a patient must: (1) reside in the United States or Puerto Rico; (2) have a valid prescription for DAWNZERA for an FDA-approved indication; and (3) be a new patient who has not previously been treated with DAWNZERA . This offer is limited to one use per patient per lifetime and is non-transferable. DAWNZERA supplied through the FTP will (i) be dispensed only by a pharmacy designated by Ionis; (ii) be delivered only to the patient's home address (no P.O. boxes) and (iii) not exceed a one-dose supply; no refills are available through the FTP.

It is unlawful for any person to sell, purchase, trade, barter, or export DAWNZERA supplied through the FTP or make an offer to do so. Patients, pharmacists, and prescribers may not seek reimbursement, either directly or indirectly, for DAWNZERA supplied through the FTP from health insurance or any third-party payer, including Medicare, Medicaid, and commercial insurance plans. Patients must not count the value of the FTP product as an expense incurred for purposes of determining patient out-of- pocket costs under any health insurance program, including Medicare Part D True Out-of-Pocket ("TrOOP") costs. THE FTP IS NOT HEALTH INSURANCE. The FTP is not a discount, rebate, coupon, cost-sharing program, or other form of financial assistance. Obtaining DAWNZERA through the FTP is not contingent on any past, present, or future purchase of DAWNZERA. To continue a patient on therapy after such one-time use, a separate prescription must be written by the healthcare provider. Use of the FTP is void where prohibited by law and where use is prohibited by the patient's insurance provider. Ionis reserves the right to rescind, revoke, or amend the FTP at any time without notice.